3 Dividend Kings to Buy in July

Dividend Kings spotlight: Procter & Gamble raised its streak to a 70th consecutive dividend increase, with Q3 core EPS of $1.59 vs $1.5552 estimate and net sales up 7% YoY, though tariffs (~$400M after-tax) and commodities (~$150M) are compressing gross margin by ~100 bps and guidance shifts to the lower end of $6.83–$7.09. Genuine Parts is the near-term catalyst trade as shares are up 20% over a month to $117.67 while quarterly dividends rose 3% to $1.0625 (yield ~4%), and a tax-free separation into Global Automotive/Global Industrial is targeted for Q1 2027. Altria offers a near-6% yield and is executing on cash flow with Q1 FY26 adjusted diluted EPS of $1.32 vs $1.25 expected and revenue up 20% YoY, reaffirming FY26 adjusted EPS guidance of $5.56–$5.72, partially offset by a ~5% decline in domestic cigarette volume.

Analysis

PG is the cleanest quality-duration exposure here, but the market is already paying up for that stability. The real mechanism is not dividend growth; it is whether its pricing engine can outrun input-cost drift without forcing a bigger mix shift into private label at mass retailers and clubs. If tariff pressure lingers into the next 1-2 quarters, the stock can still work defensively, but upside should be capped unless margin recovery shows up in the next update.

GPC is the better near-term catalyst, but it is also the most fragile on expectations. The recent rerate means July 21 is more of a proof point than a discovery event: if margins hold and credit losses normalize, the market can start underwriting the 2027 split as a real sum-of-parts unlock; if not, the move likely mean-reverts. Second-order, the supplier-bankruptcy write-off is a warning that distribution names with weak working-capital discipline can see earnings volatility long before top-line weakness appears.

MO is a yield instrument, not a growth compounder, and that distinction matters while rates stay sticky. The market appears comfortable with the payout, but the underappreciated risk is that every point of volume erosion forces more reliance on price, which can slow even a well-defended cash flow base. Consensus is missing that the equity may be safer than cigarettes but still not cheap if the business keeps shrinking; the move is likely over-owned in income portfolios and under-protected against a rate-backed de-rating.

Key Decisions for Investors

• Buy PG on weakness for a 6-12 month hold; best expression is quality compounding, but trim if tariff/commodity headwinds force another margin downgrade on the next print.
• For GPC, wait for the July 21 earnings catalyst and consider a short-dated call spread only if management confirms margin stability; if the stock fails to hold recent gains after earnings, fade the rerating.
• Keep MO as an income-only position, not a core capital-appreciation idea; if already owned, finance it with covered calls because the upside is limited unless rates fall materially.
• Relative value: long PG / short a higher-beta consumer basket or retail proxy if macro risk rises; PG should outperform on defensiveness, but the pair works only if pricing power remains intact.
• No fresh long in GPC ahead of the print unless you have conviction on the spin and guidance path; the market is already discounting a lot of the 2027 value unlock.